Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2b, Multicenter, Randomized, Double Blind, Titration Trial for Efficacy and Safety of HDV Insulin Lispro in Combination With a Basal Insulin Versus Insulin Lispro in Combination With a Basal Insulin in Patients With Type 1 Diabetes

NCT02794155 is registered in ClinicalTrials.gov with Diasome Pharmaceuticals as lead sponsor.

NCT NCT02794155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02794155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2b, Multicenter, Randomized, Double Blind, Titration Trial for Efficacy and Safety of HDV Insulin Lispro in Combination With a Basal Insulin Versus Insulin Lispro in Combination With a Basal Insulin in Patients With Type 1 Diabetes
Lead sponsor
Diasome Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2016
Completion date
June 15, 2018
Enrollment
157 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus